Welcome to Westonci.ca, where finding answers to your questions is made simple by our community of experts. Explore thousands of questions and answers from knowledgeable experts in various fields on our Q&A platform. Get quick and reliable solutions to your questions from a community of experienced experts on our platform.

buys ss, partridge e, black a, johnson cc, lamerato l, isaacs c, et al. effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (plco) cancer screening randomized controlled trial. jama 2011;305: 2295–303.

Sagot :

In the intervention group, 212 women (5.7 per 10,000 person-years) and 176 (4.7 per 10,000 person-years) received an ovarian cancer diagnosis (rate ratio [RR], 1.21; 95% confidence interval [CI], 0.99-1.48).

In the intervention group, there were 118 ovarian cancer-related deaths (3.1 per 10,000 person-years), compared to 100 in the standard care group (mortality RR, 1.18; 95% CI, 0.82-1.71).

1080 of the 3285 women who had false-positive test results underwent surgical follow-up, and 163 of them (15%) had at least one significant consequence.

Except for ovarian, colorectal, and lung cancer, there were 2924 deaths from other causes (76.6 per 10 000 person-years) in the intervention group and 2914 deaths (76.2 per 10 000 person-years)

Simultaneous screening with CA-125 and transvaginal ultrasound in comparison to standard treatment did not lower ovarian cancer mortality among women in the general US population. Complications were linked to diagnostic examination after a false-positive screening test result.

To learn more about ovarian cancer here:-

https://brainly.com/question/25637266?referrer=searchResults

#SPJ4